Metabolic reprogramming is a key step in oncogenic transformation including the activation of energy- and anabolic metabolism. Thus, differentiated cells reenter the cell cycle and proliferate. The central metabolism is the ultimate source of energy and building blocks enabling growth and proliferation. Specifically the time resolved analysis of central metabolic pathways allows an insight in metabolic dynamics and allows the comparison and even quantification of pathway usage (Liu et al. 2012). Glucose and glutamine were identified as the major fuel sources for cancer cells. Thus, glycolysis and glutaminolysis are central metabolic pathways that may possess molecular targets for an effective metabolic treatment of cancer cells not only in vitro but also in vivo. However, until now the activity of glutaminolysis in vivo is still under debate. Although a high glutaminolytic activity can be observed in cell cultures the in vivo-activity of this pathway has rarely been shown. To better characterize the metabolic activity of hepatocellular carcinoma (HCC) we studied a mouse model for HCC by analyzing the metabolome, proteome and usage of glucose and glutamine by 13C stable isotope labeling in vivo. The data show that in vivo-metabolism is strongly transformed (metabolic reprogramming) and characterized by altered usage of glucose and glutamine. Further analyses and integration of the multilevel data may allow identifying molecular targets within central metabolism. Liu L. et al. (2012) Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 483(7391):608-12.

Analyzing and targeting cancer metabolism in vivo / G. Mastrobuoni, O. Demedova, C. Bielow, M. Orioli, H. Kuich, T. Opialla, A. Kettelhake, T. Cramer, S. Kempa - In: From Omics to Novel Therapies in Cancer 2014 / H. Kuich, T. Opialla, M. Orioli, C. Bielow, G. Mastrobuoni, S. Kempa. - [s.l] : MDC Berlin, 2014 May. - pp. 69-70 (( convegno From Omics to Novel Therapies in Cancer : May, 23-24 tenutosi a Berlin nel 2014.

Analyzing and targeting cancer metabolism in vivo

M. Orioli;
2014-05

Abstract

Metabolic reprogramming is a key step in oncogenic transformation including the activation of energy- and anabolic metabolism. Thus, differentiated cells reenter the cell cycle and proliferate. The central metabolism is the ultimate source of energy and building blocks enabling growth and proliferation. Specifically the time resolved analysis of central metabolic pathways allows an insight in metabolic dynamics and allows the comparison and even quantification of pathway usage (Liu et al. 2012). Glucose and glutamine were identified as the major fuel sources for cancer cells. Thus, glycolysis and glutaminolysis are central metabolic pathways that may possess molecular targets for an effective metabolic treatment of cancer cells not only in vitro but also in vivo. However, until now the activity of glutaminolysis in vivo is still under debate. Although a high glutaminolytic activity can be observed in cell cultures the in vivo-activity of this pathway has rarely been shown. To better characterize the metabolic activity of hepatocellular carcinoma (HCC) we studied a mouse model for HCC by analyzing the metabolome, proteome and usage of glucose and glutamine by 13C stable isotope labeling in vivo. The data show that in vivo-metabolism is strongly transformed (metabolic reprogramming) and characterized by altered usage of glucose and glutamine. Further analyses and integration of the multilevel data may allow identifying molecular targets within central metabolism. Liu L. et al. (2012) Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 483(7391):608-12.
Settore CHIM/08 - Chimica Farmaceutica
Molekulares Krebsforschungszentrum
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
http://mkfz.charite.de/aktuelles/tagungen/ftic_2014/
Book Part (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/260931
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact